Dr Purwar is associate professor in the Department of Biosciences and Bioengineering at IIT Bombay and CEO of Immuno ACT.
November 02, 2023 07:07 IST
The drugs regulator has granted market authorisation to India's breakthrough CAR-T cell therapy for patients with B-cell lymphomas who didn't respond to standard treatments like chemotherapy.
